	Development and Validation of a Tool to Measure Documented Health Care Encounter Time. JAMA Netw Open Chow R, Bayrakdarian S, Gojsevic O, MacMillan E, Balboni T, Bowen J, Bruera E, Chan RJ, Gupta A, Hart NH, Hoskin P, Hui D, Iihara H, Jefford M, Lee SF, Riechelmann R, Rugo HS, Ruhlmann CH, Simone CB 2nd, Wong HCY, Zimmermann C, Chung H, Richards GC, Heneghan C, Leigh J, MASCC Emerging Toxicities Study Group. PMID: 42848401 [PubMed - indexed for MEDLINE]
	Disitamab Vedotin Plus Tislelizumab in Transurethrally Unresectable, ERBB2-Positive, Non-Muscle-Invasive Bladder Cancer: A Nonrandomized Clinical Trial. JAMA Oncol Qie Y, Jia K, Huang S, Zhao J, Xue Z, Guo S, Zhang T, Wu Z, Shen C, Hu H. PMID: 42848391 [PubMed - as supplied by publisher]
	Clinical efficacy and safety of second-line cabozantinib after first-line immune checkpoint inhibitor-based combinations in metastatic renal cell carcinoma: a multicenter retrospective study. Int J Clin Oncol Matsukawa A, Kato T, Oki M, Takao T, Inoki L, Sato M, Okada K, Maekawa T, Imanaka T, Nakayama J, Tomiyama E, Nagahara A, Ishizuya Y, Hayashi T, Yamamoto Y, Hatano K, Kawashima A, Nakayama M, Takayama H, Ono Y, Takada S, Nishimura K, Fujita K, Imamura R, Nonomura N. PMID: 42848309 [PubMed - as supplied by publisher]
	Summary of Research:Â Health-Related Quality-of-Life Profile and Clinical Outcomes in First-Line Advanced Renal Cell Carcinoma: A Modeling Analysis Based on the CheckMate 9ER Study. Adv Ther Cella D, Derosa M, Floden L, Giles RH, Lothgren M, Ogareva A, Powles T, Purnajo I, Choueiri TK, Bergerot C, Motzer RJ, Bedke J. PMID: 42848188 [PubMed - as supplied by publisher]
	Retroperitoneal lymph node dissection for isolated node recurrence of renal cell carcinoma after nephrectomy: a systematic review. World J Urol Costa Silva A, Clarke N, Gulamhusein A. PMID: 42848085 [PubMed - indexed for MEDLINE]
	Exploratory Analysis of Peri-Prostatic Adipose Tissue Radiomics Features and Their Potential to Predict Prostate Cancer Diagnosis: Results From a UK Biobank Study. Prostate O'Neill A, O'Keeffe R, Winter S, Dorrian J, Gaunt TR, Guönason V, Travis RC, Martin RM, Allott EH, Leech M. PMID: 42847696 [PubMed - as supplied by publisher]
	Characteristics and Treatment Patterns of Patients with Muscle-Invasive Bladder Cancer in the United States: A Real-World Cohort Study. Pragmat Obs Res Gore JL, Thompson A, Kelkar SS, Chirikov V, Kamat S, Quan W, Donnowitz K, Young C, Nimke D, Quicquaro CM, Willmon CL, Pednekar P. PMID: 42846494 [PubMed]
	Immunosuppressive cell populations as potential drivers of extrinsic immune checkpoint inhibition resistance in clear cell renal cell carcinoma. Oncol Rev Temuri UH. PMID: 42846110 [PubMed]
	Improved survival in newly diagnosed metastatic prostate cancer: a National Prostate Cancer Audit study. BJU Int Nathan A, Parry MG, Mayne E, Cook A, Liu J, Varma R, Cuningham W, Dodkins J, Parry M, Nossiter J, Aggarwal A, van der Meulen J, Tree A, Clarke N. PMID: 42845147 [PubMed - as supplied by publisher]
	MITF-Overexpressing Perivascular Epithelioid Cell Tumor of the Urinary Bladder Lacking TSC1/TSC2 Alterations and TFE3 Rearrangement: A Case Report and Review of the Literature. Pathol Int Jeong JI, Lee J, Oh MH, Cho HD, Lee JH, Jeon YS, Jang SH. PMID: 42844916 [PubMed - indexed for MEDLINE]
	Longitudinally Monitoring Prostate Cancer Bone Metastasis and Treatment Response via Circulating Extracellular Vesicles. J Extracell Vesicles Gentile E, Corn PG, Zavridou M, Long JP, Song JH, Hoang A, Hahn AW, Dondossola E, Norton W, Lin SH, Logothetis CJ, Panaretakis T. PMID: 42844644 [PubMed - indexed for MEDLINE]
	A novel "early warning" system for biochemical recurrence in prostate cancer: development and validation of the SII-HALP combined score. BMC Cancer Wang Y, Fu G, Han D, Ye D. PMID: 42844604 [PubMed - indexed for MEDLINE]
	Critical appraisal of artificial intelligence studies for prostate cancer detection on MRI. Eur Radiol Pooch E, Agrotis G, Schoots IG, Emberton M, Kasivisvanathan V, Hu Y. PMID: 42844397 [PubMed - as supplied by publisher]
	Tislelizumab plus lenvatinib in advanced fumarate hydratase-deficient renal cell carcinoma: a single-arm, phase 2 trial with metabolic biomarker analysis. Nat Commun Kong W, Xu Y, Liu G, Lv W, Wang Z, Cao D, Jiao F, Hu J, Wu X, Huang J, Chen Y, Zhai W, Wu X, Pan J, Huang Y, Wu G, Zheng L, Xue W, Zhang J. PMID: 42844281 [PubMed - indexed for MEDLINE]
	Younger Age Is Associated With Slower PSA Decline After Low-Dose-Rate Brachytherapy for Localized Prostate Cancer. Int J Urol Nakai Y, Onishi K, Miyake M, Yamaki K, Isohashi F, Asakawa I, Tanaka N. PMID: 42844157 [PubMed - indexed for MEDLINE]
	Treatment-Effect Heterogeneity and a Simple Framework for Estimating Survival Benefit Associated With Local Therapy in Nonmetastatic Advanced Prostate Cancer: A Multicenter KAMU-ON Cohort Study. Int J Urol Iwamoto H, Izumi K, Machioka K, Toriumi R, Shima T, Nozaki M, Hori T, Inaba T, Nakagawa R, Kamijima T, Kadomoto S, Makino T, Naito R, Yaegashi H, Shigehara K, Nohara T, Miyagi T, Seto C, Kadono Y, Mizokami A. PMID: 42844150 [PubMed - indexed for MEDLINE]
	Re: Benedikt Hoeh, Giovanni Mazzucato, Pierre Tennstedt, et al. Natural History of Patients Eligible for PROTEUS Diagnosed with Prostate Cancer and Treated with Radical Prostatectomy Without Perioperative Systemic Treatment. Eur Urol Focus. In press. http://dx.doi.org/10.1016/j.euf.2026.05.002. Eur Urol Focus Rodriguez-Sanchez L, Giannarini G, Gomez-Rivas J, EAU Oncology Section Prostate Cancer Working Group. PMID: 42844119 [PubMed - as supplied by publisher]
	Oncological Outcomes of Neoadjuvant Chemotherapy in High-Risk UTUC: A Multicenter Study. Int J Urol Saito S, Sazuka T, Washino S, Kaneko G, Nagamoto S, Nakamura Y, Nakayama A, Pae S, Ando K, Yamada Y, Imamura Y, Sakamoto S. PMID: 42843987 [PubMed - indexed for MEDLINE]
	Clinical utility of combining the C-reactive protein-to-albumin ratio and systemic immune-inflammation index for prognostic assessment in metastatic renal cell carcinoma. PLoS One Muramoto N, Nagata M, Hirano H, Shirakawa T, China T, Kawano H, Isotani S, Ide H, Honda H, Horie S. PMID: 42842585 [PubMed - indexed for MEDLINE]
	Bridging the implementation gap in hereditary cancer care for prostate cancer: a narrative review and Japanese environmental scan. Int J Clin Oncol Habano E, Sato Y, Ogawa M, Watanabe K, Akiyama N, Chang H, Shijiki E, Nagai S, Kunita A, Ueki A, Kage H, Oda K. PMID: 42842178 [PubMed - as supplied by publisher]

Articles 1 - 20 / 182028

Page 1 of 9102



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy